Clinical-Scale Production of CAR-T Cells for the Treatment of Melanoma Patients by mRNA Transfection of a CSPG4-Specific CAR under Full GMP Compliance
- Supplementary File 1:
PDF-Document (PDF, 824 KiB)
Wiesinger, M.; März, J.; Kummer, M.; Schuler, G.; Dörrie, J.; Schuler-Thurner, B.; Schaft, N. Clinical-Scale Production of CAR-T Cells for the Treatment of Melanoma Patients by mRNA Transfection of a CSPG4-Specific CAR under Full GMP Compliance. Cancers 2019, 11, 1198. https://doi.org/10.3390/cancers11081198
Wiesinger M, März J, Kummer M, Schuler G, Dörrie J, Schuler-Thurner B, Schaft N. Clinical-Scale Production of CAR-T Cells for the Treatment of Melanoma Patients by mRNA Transfection of a CSPG4-Specific CAR under Full GMP Compliance. Cancers. 2019; 11(8):1198. https://doi.org/10.3390/cancers11081198
Chicago/Turabian StyleWiesinger, Manuel; März, Johannes; Kummer, Mirko; Schuler, Gerold; Dörrie, Jan; Schuler-Thurner, Beatrice; Schaft, Niels. 2019. "Clinical-Scale Production of CAR-T Cells for the Treatment of Melanoma Patients by mRNA Transfection of a CSPG4-Specific CAR under Full GMP Compliance" Cancers 11, no. 8: 1198. https://doi.org/10.3390/cancers11081198